Induced pluripotent stem cells and Parkinson's disease: modelling and treatment

被引:13
作者
Xu, Xiaoyun [1 ]
Huang, Jinsha [1 ]
Li, Jie [1 ]
Liu, Ling [1 ]
Han, Chao [1 ]
Shen, Yan [1 ]
Zhang, Guoxin [1 ]
Jiang, Haiyang [1 ]
Lin, Zhicheng [2 ]
Xiong, Nian [1 ]
Wang, Tao [1 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, 1277 Jiefang Rd, Wuhan 430022, Hubei, Peoples R China
[2] Harvard Univ, McLean Hosp, Mailman Neurosci Res Ctr, Dept Psychiat,Med Sch,Div Alcohol & Drug Abuse, Belmont, MA 02178 USA
基金
中国国家自然科学基金;
关键词
MIDBRAIN DOPAMINERGIC-NEURONS; IPSC-DERIVED NEURONS; PRIMATE MODEL; HIGHLY EFFICIENT; RAT MODEL; NEURAL PRECURSORS; OXIDATIVE STRESS; IN-VITRO; GENERATION; DIFFERENTIATION;
D O I
10.1111/cpr.12229
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many neurodegenerative disorders, such as Parkinson's disease (PD), are characterized by progressive neuronal loss in different regions of the central nervous system, contributing to brain dysfunction in the relevant patients. Stem cell therapy holds great promise for PD patients, including with foetal ventral mesencephalic cells, human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Moreover, stem cells can be used to model neurodegenerative diseases in order to screen potential medication and explore their mechanisms of disease. However, related ethical issues, immunological rejection and lack of canonical grafting protocols limit common clinical use of stem cells. iPSCs, derived from reprogrammed somatic cells, provide new hope for cell replacement therapy. In this review, recent development in stem cell treatment for PD, using hiPSCs, as well as the potential value of hiPSCs in modelling for PD, have been summarized for application of iPSCs technology to clinical translation for PD treatment.
引用
收藏
页码:14 / 26
页数:13
相关论文
共 50 条
[31]   Induced Pluripotent Stem Cell Technology and Direct Conversion: New Possibilities to Study and Treat Parkinson's Disease [J].
Roessler, Reinhard ;
Boddeke, Erik ;
Copray, Sjef .
STEM CELL REVIEWS AND REPORTS, 2013, 9 (04) :505-513
[32]   Activation of Embryonic Gene Transcription in Neural Precursor Cells Derived from the Induced Pluripotent Stem Cells of the Patients with Parkinson's Disease [J].
Fedoseyeva, Viya B. ;
Novosadova, Ekaterina V. ;
Nenasheva, Valentina V. ;
Novosadova, Lyudmila V. ;
Grivennikov, Igor A. ;
Tarantul, Vyacheslav Z. .
BIOCHEMISTRY-MOSCOW, 2023, 88 (04) :515-525
[33]   Challenges involved in cell therapy for Parkinson's disease using human pluripotent stem cells [J].
Moon, Heechang ;
Kim, Bokwang ;
Kwon, Inbeom ;
Oh, Yohan .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
[34]   Livestock Induced Pluripotent Stem Cells [J].
Lu, Y. ;
Mumaw, J. L. ;
West, F. D. ;
Stice, S. L. .
REPRODUCTION IN DOMESTIC ANIMALS, 2012, 47 :72-76
[35]   Modeling Huntington's disease with induced pluripotent stem cells [J].
Kaye, Julia A. ;
Finkbeiner, Steven .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 56 :50-64
[36]   Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening [J].
Aboul-Soud, Mourad A. M. ;
Alzahrani, Alhusain J. ;
Mahmoud, Amer .
CELLS, 2021, 10 (09)
[37]   Application of induced pluripotent stem cells to hematologic disease [J].
Kim, Peter Geon ;
Daley, George Q. .
CYTOTHERAPY, 2009, 11 (08) :980-989
[38]   Induced Pluripotent Stem Cells and Outer Retinal Disease [J].
Yang, Jin ;
Cai, Bingcui ;
Glencer, Patrick ;
Li, Zhiqing ;
Zhang, Xiaomin ;
Li, Xiaorong .
STEM CELLS INTERNATIONAL, 2016, 2016
[39]   Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells [J].
Dupuis, Victoria ;
Oltra, Elisa .
WORLD JOURNAL OF STEM CELLS, 2021, 13 (08) :1094-1111
[40]   Induced Pluripotent Stem Cells for Ischemic Stroke Treatment [J].
Duan, Ranran ;
Gao, Yang ;
He, Ruya ;
Jing, Lijun ;
Li, Yanfei ;
Gong, Zhe ;
Yao, Yaobing ;
Luan, Tingting ;
Zhang, Chaopeng ;
Li, Li ;
Jia, Yanjie .
FRONTIERS IN NEUROSCIENCE, 2021, 15